Business, energy, technology, markets and global industry news from Business News Today

obstructive sleep apnea

PharmaDeviceNews obstructive sleep apnea
Representative image of a sleep medicine setting as Apnimed’s AD109 oral therapy advances debate over obstructive sleep apnea treatment, Phase 3 data, and potential FDA review.
Pharma & Biotech

Apnimed advances oral OSA therapy case as AD109 heads toward FDA decision window

Find out how Apnimed’s AD109 Phase 3 data could reshape oral treatment for obstructive sleep apnea as FDA review approaches.

Read More
Representative image of a hypoglossal nerve stimulation implant procedure used in obstructive sleep apnea treatment, reflecting how LivaNova PLC’s aura6000 System FDA approval could expand eligibility beyond traditional PAP therapy patients.
Medical Devices & Diagnostics

LivaNova PLC expands sleep apnea eligibility as aura6000 gains FDA approval without CCC limits

LivaNova PLC secures FDA approval for aura6000. Discover how it could reshape sleep apnea treatment and expand patient eligibility.

Read More